No Data
Norse (301333.SZ) has spent 56.0627 million yuan to repurchase 1.49% of its shares.
Nossgar (301333.SZ) issued an announcement that as of December 31, 2024, the company will conduct a buyback specifically...
Both Private Companies Who Control a Good Portion of R&G PharmaStudies Co., Ltd. (SZSE:301333) Along With Institutions Must Be Dismayed After Last Week's 6.7% Decrease
Norseld (301333.SZ): Cumulatively repurchased 1.49% of shares.
Gridlive, December 2nd - Nosige (301333.SZ) announced that as of November 30, 2024, the company has repurchased 1,442,000 shares of the company through a repurchase special securities account in a centralized auction trading manner, accounting for approximately 1.49% of the company's current total share capital of 96,581,256 shares. The highest fill price was 43.15 yuan/share, the lowest fill price was 35.06 yuan/share, and the total fill amount was 56,062,734.00 yuan (excluding transaction fees).
Norsec (301333.SZ) shareholders Harmony Growth Phase II, Harmony Health Plan to reduce their shareholding by no more than 2.56 million shares
Norse Engineering (301333.SZ) announced that the company's shareholders, Harmony Growth Phase II and Harmony Health, plan to reduce their shareholding in the company, and...
Some May Be Optimistic About R&G PharmaStudies' (SZSE:301333) Earnings
Norsen (301333.SZ): has repurchased 1.49% of shares accumulated.
Gelonghui November 5th丨Norssi格(301333.SZ) announced that as of October 31, 2024, the company has repurchased 1,442,000 shares of the company through a repurchase special securities account in the centralized competitive trading method, accounting for approximately 1.49% of the company's current total share capital of 96,581,256 shares. The highest fill price was 43.15 yuan/share, the lowest fill price was 35.06 yuan/share, and the total fill amount was 56,062,734.00 yuan (excluding transaction costs).
